RedHill Releases Update on Promising IBD Therapies

RedHill Releases Update on Promising IBD Therapies
Israel-based biopharmaceutical company RedHill Biopharma recently released an update on the development of its drug pipeline, including a treatment for Crohn’s disease, and announced key milestones expected by the company for the upcoming period. RedHill specializes in developing and commercializing oral, small molecule drugs to treat inflammatory and gastrointestinal diseases such as gastrointestinal cancers. RedHill is developing RHB-104 as a potential treatment for Crohn’s

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *